CLINICAL TRIALS PROFILE FOR DEXYCU KIT
✉ Email this page to a colleague
All Clinical Trials for DEXYCU KIT
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02006888 ↗ | The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery | Completed | ICON Bioscience Inc | Phase 3 | 2014-01-01 | The purpose of this study is to determine whether IBI-10090 injection is effective in the treatment of inflammation associated with cataract surgery. |
| NCT02547623 ↗ | Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery | Completed | ICON Bioscience Inc | Phase 3 | 2015-11-06 | The study is a prospective, randomized, parallel-design, multicenter trial in patients ≥40 years of age undergoing cataract surgery. Patients who meet all inclusion and no exclusion criteria will be randomized to 1 of 2 treatment groups - A single 5 mcl anterior chamber injection of IBI 10090, 103.4 mcg/mcl dexamethasone, equivalent dexamethasone dose: 517 mcg at the conclusion of cataract surgery or; - Prednisolone acetate ophthalmic suspension 1% eye drops administered 1 drop 4 times daily (QID) for 3 weeks Safety will be assessed by adverse events (AEs), slit lamp biomicroscopy, fundus examination, intraocular pressure (IOP), visual acuity, and specular microscopy endothelial cell count. |
| NCT04184999 ↗ | Effect of Intraoperative Dexamethasone on Post-op Dry Eye | Completed | SR Cornea Consultants | Phase 4 | 2019-08-10 | To compare the signs and symptoms of dry eye after cataract surgery between subjects randomized to receive intraoperative dexamethasone in addition to the use of a standard topical post-op treatment regimen. |
| NCT04273282 ↗ | A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% | Completed | MDbackline, LLC | Phase 4 | 2019-12-16 | This is a post-approval, open-label, randomized, self-controlled prospective clinical study to evaluate the safety and ocular efficacy of Dexycu in controlling postoperative ocular pain and inflammation associated with cataract surgery. |
| NCT04273282 ↗ | A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% | Completed | Research Insight LLC | Phase 4 | 2019-12-16 | This is a post-approval, open-label, randomized, self-controlled prospective clinical study to evaluate the safety and ocular efficacy of Dexycu in controlling postoperative ocular pain and inflammation associated with cataract surgery. |
| NCT04316936 ↗ | Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery | Recruiting | Ocular Therapeutix, Inc. | Phase 4 | 2019-12-10 | This research will evaluate the efficacy of Omidria and Dexycu, Omidria and Dextenza, and Omidria and prednisolone acetate 1% in the resolution of post-operative inflammation and pain following cataract surgery. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DEXYCU KIT
Condition Name
Clinical Trial Locations for DEXYCU KIT
Trials by Country
Clinical Trial Progress for DEXYCU KIT
Clinical Trial Phase
Clinical Trial Sponsors for DEXYCU KIT
Sponsor Name
